Day One Bio Advocacy Community Meeting
It is my pleasure to invite you to the…
Day One Bio Advocacy Community Meeting
Friday, August 5, 2022
12:00 p.m. EST
During this one-hour Zoom meeting, Day One Vice President of Clinical Development Michael Cox will provide an update regarding tovorafenib (DAY101) and pimasertib clinical programs for children, adolescents, and young adults with certain cancers.
In addition, we will share results of the patient advocacy survey many of you participated in earlier this year. This research informs Day One’s approach to supporting pediatric cancer non-profit organizations and the patients and families you represent. We welcome your feedback about what the survey results are telling us.
Please register using the link below:
We look forward to your questions and comments and to a great discussion!
Best regards,
Christa
—
Christa Kerkorian
Vice President, Patient Advocacy
Day One Bio
M: 650-438-9717
Comments are closed.